AngioDynamics Historical Income Statement
| ANGO Stock | USD 6.12 0.21 3.32% |
Historical analysis of AngioDynamics income statement accounts such as Interest Expense of 1.7 M, Total Revenue of 242.9 M or Gross Profit of 129.6 M can show how well AngioDynamics performed in making a profits. Evaluating AngioDynamics income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of AngioDynamics's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining AngioDynamics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether AngioDynamics is a good buy for the upcoming year.
AngioDynamics |
About AngioDynamics Income Statement Analysis
AngioDynamics Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to AngioDynamics shareholders. The income statement also shows AngioDynamics investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
AngioDynamics Income Statement Chart
AngioDynamics Income Statement is one of the three primary financial statements used for reporting AngioDynamics's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of AngioDynamics revenue and expense. AngioDynamics Income Statement primarily focuses on the company's revenues and expenses during a particular period.
As of the 19th of April 2024, Discontinued Operations is likely to grow to about 87.5 M, while Depreciation And Amortization is likely to drop about 17.8 M. Add Fundamental
Total Revenue
Total revenue comprises all receipts AngioDynamics generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Gross Profit
Gross profit is a required income statement account that reflects total revenue of AngioDynamics minus its cost of goods sold. It is profit before AngioDynamics operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of AngioDynamics. It is also known as AngioDynamics overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Most accounts from AngioDynamics' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into AngioDynamics current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AngioDynamics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. To learn how to invest in AngioDynamics Stock, please use our How to Invest in AngioDynamics guide.As of the 19th of April 2024, Discontinued Operations is likely to grow to about 87.5 M, while Depreciation And Amortization is likely to drop about 17.8 M.
| 2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 165.7M | 174.2M | 200.4M | 129.6M | Total Revenue | 316.2M | 338.8M | 389.6M | 242.9M |
AngioDynamics income statement Correlations
Click cells to compare fundamentals
AngioDynamics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
AngioDynamics income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | 23.8M | 25.9M | 29.3M | 30.9M | 35.5M | 17.8M | |
| Interest Expense | 907K | 861K | 688K | 2.7M | 3.1M | 1.7M | |
| Total Revenue | 264.2M | 291.0M | 316.2M | 338.8M | 389.6M | 242.9M | |
| Gross Profit | 150.3M | 156.8M | 165.7M | 174.2M | 200.4M | 129.6M | |
| Other Operating Expenses | 278.2M | 306.0M | 334.4M | 357.4M | 411.0M | 233.3M | |
| Operating Income | (14.2M) | (14.9M) | (19.0M) | (19.2M) | (17.3M) | (16.4M) | |
| Ebit | (14.2M) | (14.9M) | (19.0M) | (19.2M) | (22.1M) | (21.0M) | |
| Research Development | 29.7M | 36.4M | 30.7M | 29.9M | 34.4M | 21.4M | |
| Ebitda | 9.6M | 11.0M | 10.3M | 11.6M | 13.4M | 12.7M | |
| Cost Of Revenue | 113.9M | 134.2M | 150.5M | 164.5M | 189.2M | 113.3M | |
| Total Operating Expenses | 164.3M | 171.8M | 183.9M | 192.9M | 221.9M | 120.0M | |
| Income Before Tax | (167.1M) | (36.1M) | (29.9M) | (54.4M) | (49.0M) | (46.5M) | |
| Total Other Income Expense Net | (153.0M) | (21.2M) | (10.9M) | (35.2M) | (31.7M) | (30.1M) | |
| Net Income | (165.8M) | (31.5M) | (26.5M) | (52.4M) | (47.2M) | (44.8M) | |
| Income Tax Expense | (1.3M) | (4.5M) | (3.4M) | (2.0M) | (1.8M) | (1.7M) | |
| Selling General Administrative | 37.9M | 35.9M | 38.5M | 40.0M | 46.0M | 27.5M | |
| Net Income Applicable To Common Shares | (166.8M) | (31.5M) | (26.5M) | (52.4M) | (47.2M) | (44.8M) | |
| Selling And Marketing Expenses | 78.6M | 81.3M | 95.3M | 104.2M | 119.9M | 73.9M | |
| Net Income From Continuing Ops | (166.8M) | (31.5M) | (26.5M) | (52.4M) | (47.2M) | (44.8M) | |
| Non Operating Income Net Other | (1.0M) | 92K | (790K) | (554K) | (637.1K) | (669.0K) | |
| Non Recurring | 153.1M | 20.3M | 10.3M | 32.5M | 37.4M | 30.9M | |
| Tax Provision | (1.3M) | (4.5M) | (3.4M) | (2.0M) | (1.8M) | (1.7M) | |
| Net Interest Income | (907K) | (861K) | (688K) | (2.7M) | (3.1M) | (3.3M) | |
| Reconciled Depreciation | 23.8M | 25.9M | 29.3M | 30.9M | 35.5M | 28.9M |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards AngioDynamics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, AngioDynamics' short interest history, or implied volatility extrapolated from AngioDynamics options trading.
Pair Trading with AngioDynamics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AngioDynamics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AngioDynamics will appreciate offsetting losses from the drop in the long position's value.Moving against AngioDynamics Stock
| 0.54 | CVS | CVS Health Corp Financial Report 1st of May 2024 | PairCorr |
| 0.51 | VMD | Viemed Healthcare | PairCorr |
| 0.5 | COO | Cooper Companies Financial Report 6th of June 2024 | PairCorr |
| 0.45 | CAH | Cardinal Health Financial Report 2nd of May 2024 | PairCorr |
The ability to find closely correlated positions to AngioDynamics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AngioDynamics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AngioDynamics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AngioDynamics to buy it.
The correlation of AngioDynamics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AngioDynamics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AngioDynamics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AngioDynamics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AngioDynamics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. To learn how to invest in AngioDynamics Stock, please use our How to Invest in AngioDynamics guide.Note that the AngioDynamics information on this page should be used as a complementary analysis to other AngioDynamics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Complementary Tools for AngioDynamics Stock analysis
When running AngioDynamics' price analysis, check to measure AngioDynamics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AngioDynamics is operating at the current time. Most of AngioDynamics' value examination focuses on studying past and present price action to predict the probability of AngioDynamics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AngioDynamics' price. Additionally, you may evaluate how the addition of AngioDynamics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |
Is AngioDynamics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AngioDynamics. If investors know AngioDynamics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AngioDynamics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.80) | Revenue Per Share 8.105 | Quarterly Revenue Growth (0.07) | Return On Assets (0.05) | Return On Equity (0.62) |
The market value of AngioDynamics is measured differently than its book value, which is the value of AngioDynamics that is recorded on the company's balance sheet. Investors also form their own opinion of AngioDynamics' value that differs from its market value or its book value, called intrinsic value, which is AngioDynamics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AngioDynamics' market value can be influenced by many factors that don't directly affect AngioDynamics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AngioDynamics' value and its price as these two are different measures arrived at by different means. Investors typically determine if AngioDynamics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AngioDynamics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.